Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Public ClinicalTrials.gov record NCT00404001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Safety and Efficacy of Orally Administered MD-0727 in Patients With Primary Hypercholesterolemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to evaluate the safety of MD-0727 in patients with primary hypercholesterolemia and to determine the low density lipoprotein cholesterol (LDL-C) lowering effect and dose-response of MD-0727 in patients with primary hypercholesterolemia.
Study identification
- NCT ID
- NCT00404001
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Not listed
- Completion
- Jun 30, 2007
- Last update posted
- Sep 30, 2007
2006 – 2007
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Microbia Investigational Site | Birmingham | Alabama | — | — |
| Microbia Investigational Site | Los Angeles | California | — | — |
| Microbia Investigational Site | Walnut Creek | California | — | — |
| Microbia Investigational Site | New Port Richey | Florida | — | — |
| Microbia Investigational Site | Chicago | Illinois | — | — |
| Microbia Investigational Site | Indianapolis | Indiana | — | — |
| Microbia Investigational Site | Overland | Kansas | — | — |
| Microbia Investigational Site | Louisville | Kentucky | — | — |
| Microbia Investigational Site | Edina | Minnesota | — | — |
| Microbia Investigational Site | Kansas City | Missouri | — | — |
| Microbia Investigational Site | Statesville | North Carolina | — | — |
| Microbia Investigational Site | Winston-Salem | North Carolina | — | — |
| Microbia Investigational Site | Cincinnati | Ohio | — | — |
| Microbia Investigational Site | Marion | Ohio | — | — |
| Microbia Investigational Site | Charleston | South Carolina | — | — |
| Microbia Investigational Site | Bristol | Tennessee | — | — |
| Microbia Investigational Site | San Antonio | Texas | — | — |
| Microbia Investigational Site | Richmond | Virginia | — | — |
| Microbia Investigational Site | Lakewood | Washington | — | — |
| Microbia Investigational Site | Olympia | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00404001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2007 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00404001 live on ClinicalTrials.gov.